We are live on ! Find out more
ACHV icon

Achieve Life Sciences
ACHV

29 hedge funds and large institutions have $2.81M invested in Achieve Life Sciences in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% less funds holding

Funds holding: 34 → 29 (-5)

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

30% less capital invested

Capital invested by funds: $4M → $2.81M (-$1.18M)

63% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 8

Holders
29
Holders Change
-5
Holders Change %
-14.71%
% of All Funds
0.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
7
Closed
8
Calls
$4K
Puts
–
Net Calls
+$4K
Net Calls Change
-$3K

Top Buyers

1
SCP
Steamboat Capital Partners
New York
+$593K
2
PAM
Panagora Asset Management
Massachusetts
+$591K
3
BFA
BlackRock Fund Advisors
California
+$63.8K
4
UBS Group
UBS Group
Switzerland
+$54.2K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$49.4K

Top Sellers

1
ARTA
A.R.T. Advisors
New York
-$57K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$51K
3
AA
Ancora Advisors
Ohio
-$51K
4
PI
Putnam Investments
Massachusetts
-$50K
5
BA
BlackRock Advisors
Delaware
-$39.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
PAM
1
Panagora Asset Management
Massachusetts
$481K +$591K +371 +608%
Renaissance Technologies
2
Renaissance Technologies
New York
$460K +$23.9K +15 +4%
SCP
3
Steamboat Capital Partners
New York
$414K +$593K +372 New
BIT
4
BlackRock Institutional Trust
California
$394K – – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$391K -$51K -32 -8%
A
6
Abingworth
United Kingdom
$195K – – –
Geode Capital Management
7
Geode Capital Management
Massachusetts
$76K – – –
EGA
8
Eagle Global Advisors
Texas
$65K -$12.8K -8 -12%
BFA
9
BlackRock Fund Advisors
California
$47K +$63.8K +40 +2,000%
UBS Group
10
UBS Group
Switzerland
$43K +$54.2K +34 +680%
Susquehanna International Group
11
Susquehanna International Group
Pennsylvania
$35K +$49.4K +31 New
BA
12
BlackRock Advisors
Delaware
$33K -$39.9K -25 -45%
BFM
13
Boothbay Fund Management
New York
$31K +$44.6K +28 New
Northern Trust
14
Northern Trust
Illinois
$28K – – –
California Public Employees Retirement System
15
California Public Employees Retirement System
California
$25K – – –
T. Rowe Price Associates
16
T. Rowe Price Associates
Maryland
$23K – – –
Bank of New York Mellon
17
Bank of New York Mellon
New York
$19K -$4.78K -3 -15%
Goldman Sachs
18
Goldman Sachs
New York
$10K -$3.19K -2 -18%
Creative Planning
19
Creative Planning
Kansas
$10K – – –
GC
20
Guggenheim Capital
Illinois
$6K -$1.59K -1 -17%
Citigroup
21
Citigroup
New York
$5K – – –
CG
22
Cutler Group
California
$5K – – –
State Street
23
State Street
Massachusetts
$5K – – –
Morgan Stanley
24
Morgan Stanley
New York
$3K -$1.59K -1 -33%
Royal Bank of Canada
25
Royal Bank of Canada
Ontario, Canada
$3K – – –
1
2

ACHV Hedge Fund Activity: Q3 2016 in Review

29 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q3 2016, worth a combined $2.81M — down 30% from $4M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of ACHV and 3 opened new positions — a net loss of 5 holders — while 7 trimmed existing stakes and 5 added.

The largest buyer was Steamboat Capital Partners, opening a new position worth an estimated $593K. The largest seller was A.R.T. Advisors, exiting entirely with an estimated $57K sold.

  • 29 institutional investors held Achieve Life Sciences (ACHV) as of Q3 2016, down from 34 in Q2 2016.
  • Funds reported $2.81M of Achieve Life Sciences stock for Q3 2016, down 30% quarter-over-quarter.
  • 3 funds opened new Achieve Life Sciences positions in Q3 2016 and 8 closed out, a net change of -5 holders.
  • The largest Achieve Life Sciences buyer in Q3 2016 was Steamboat Capital Partners, an estimated $593K added.
  • The largest Achieve Life Sciences seller in Q3 2016 was A.R.T. Advisors, an estimated $57K sold.

Based on aggregated 13F filings for Q3 2016.